Rosetta Exosome Overview
- Year Founded
-
2016
- Status
-
Out of Business
- Employees
-
8
- Latest Deal Type
-
Out of Business
Rosetta Exosome General Information
Description
Developer of exosome isolation kits designed for diagnostics and therapeutics for intractable diseases. The company has developed a technology for exosome or extracellular vesicle isolation from mammalian cell-conditioned medium and biological fluids, enabling researchers to get advanced kits for mammalian research.
Contact Information
Website
www.rosettaexosome.comCorporate Office
- 6th Floor, 21, Daewangpangyo-ro 644beon-gil
- Bundang-gu
- Seongnam, Gyeonggi-do 13494
- South Korea
Corporate Office
- 6th Floor, 21, Daewangpangyo-ro 644beon-gil
- Bundang-gu
- Seongnam, Gyeonggi-do 13494
- South Korea
Rosetta Exosome Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 01-Jul-2023 | Completed | Out of Business | |||
| 2. Later Stage VC (Series A) | 27-Apr-2021 | Completed | Generating Revenue | |||
| 1. Seed Round | 22-Jan-2020 | $2.07M | $2.07M | Completed | Generating Revenue |
Rosetta Exosome Comparisons
Industry
Financing
Details
Rosetta Exosome Competitors (1)
One of Rosetta Exosome’s competitors is Evox Therapeutics, a Venture Capital-Backed company based in Oxford, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Evox Therapeutics | Venture Capital-Backed | Oxford, United Kingdom |
Rosetta Exosome Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Rosetta Exosome Patents
Rosetta Exosome Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023229446-A1 | Method for constructing gram-negative bacterial outer membrane-derived nanovesicles and use thereof | Inactive | 27-May-2022 | ||
| WO-2023090976-A1 | Outer membrane vesicles and composition for cancer treatment or prevention including same | Inactive | 22-Nov-2021 | ||
| EP-4361252-A1 | Commercial purification method for high-purity bacterial extracellular vesicles | Inactive | 21-Jun-2021 | ||
| US-20240293776-A1 | Commercial purification method for high-purity bacterial extracellular vesicles | Pending | 21-Jun-2021 | ||
| WO-2022270872-A1 | Commercial purification method for high-purity bacterial extracellular vesicles | Inactive | 21-Jun-2021 | B01D61/145 |
Rosetta Exosome Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Rosetta Exosome FAQs
-
When was Rosetta Exosome founded?
Rosetta Exosome was founded in 2016.
-
Where is Rosetta Exosome headquartered?
Rosetta Exosome is headquartered in Seongnam, South Korea.
-
What is the size of Rosetta Exosome?
Rosetta Exosome has 8 total employees.
-
What industry is Rosetta Exosome in?
Rosetta Exosome’s primary industry is Other Devices and Supplies.
-
Is Rosetta Exosome a private or public company?
Rosetta Exosome is a Private company.
-
What is Rosetta Exosome’s current revenue?
The current revenue for Rosetta Exosome is .
-
How much funding has Rosetta Exosome raised over time?
Rosetta Exosome has raised $9.2M.
-
Who are Rosetta Exosome’s competitors?
Evox Therapeutics is a competitor of Rosetta Exosome.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
